<DOC>
	<DOC>NCT01961102</DOC>
	<brief_summary>It is to be achieved that in postmenopausal women through the combination of Hysteroscopy and intraoperative rapid section a positive predictive value (PPV) regarding the objective illness like endometrial cancer or adenomatous hyperplasia of 100% so as a negative predictive value (NPV) of 99%.</brief_summary>
	<brief_title>OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer</brief_title>
	<detailed_description>If a patient fulfills the inclusion criteria, the surgeon decides intraoperatively due to the aspect in the hysteroscopy if it is a clearly benign result or if it looks suspicious or malign. In case of a hysteroscopical benign result the patient will be informed about the result after the operation. In case of a hysteroscopal suspicious or malignant aspect, the curettement will be sent for a rapid section. If the hysteroscopic result confirms the hysteroscopic suspicion the patient will be informed after the operation and the further treatment can be planned right away.</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Endometrial Hyperplasia</mesh_term>
	<criteria>Postmenopausal status (more than 1 year of last menopausal bleeding) Postmenopausal vaginal bleeding Asymptomatic postmenopausal endometrial hyperplasia Understanding of the german language Signature and consent of the patient Not able to understand and participate in the study Premenopausal status no informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>postmenopausal bleeding</keyword>
	<keyword>postmenopausal hyperplasia</keyword>
	<keyword>endometrial cancer</keyword>
	<keyword>atypical hyperplasia</keyword>
	<keyword>curettage</keyword>
	<keyword>intraoperative rapid section</keyword>
</DOC>